$ZVRA Cashflow Statement | Understand Stock

$ZVRA

$9.53 -$0.28 (2.85%) Close

$ZVRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Loss on extinguishment of debt
Stock-based compensation expense
Impairment of intangible assets
Inventory obsolescence charge
Income tax expense
Depreciation and amortization expense
Non-cash interest expense
Amortization of debt issuance costs and debt discount
Fair value adjustment related to derivative and warrant liability and CVR liability
Non-cash lease expense
Fair value adjustment related to warrant and CVR liabilities
Accretion on investments
Fair value adjustment related to investments
Loss on sublease and disposal of property and equipment
Acquired in-process research and development
Consulting fees paid in common stock
Loss on foreign currency exchange rates
Gain on sale of PRV

Change in assets and liabilities:
Accounts and other receivables
Prepaid expenses and other current assets
Inventories
Operating lease right-of-use assets
Other long-term assets
Accounts payable and accrued expenses
Discount and rebate liabilities
Operating lease liabilities
Other liabilities
Net cash used in operating activities
Cash flows from investing activities:
Acquisitions, net
Purchases of property and equipment
Disposals of property and equipment
Purchases of investments
Maturities of investments
Payment of royalty to XOMA
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from Public Offering, net of discounts and commissions
Proceeds from Inducement Transaction, net of discounts and commissions
Warrants Issued in Connection with January 2021 Inducement Transaction
Warrants Issued in Connection with June 2021 Inducement Transaction
Total proceeds from Inducement Transaction, net of discounts and commissions
Proceeds from issuance of debt, net of lender fees
Repayment of debt
Payment to repurchase shares as part of the Share Repurchase Program
Proceeds from equity line of credit
Proceeds from Payment Protection Program loan
Payment of offering costs
Proceeds from insurance financing arrangements
Proceeds from Employee Stock Purchase Plan
Proceeds from issuance of stock
Proceeds from issuance of common stock for options exercised
Proceeds from issuance of common stock for warrants exercised
Payments of principal on insurance financing arrangements
Payment of deferred financing costs
Repayment of principal on finance lease liabilities
Payment of debt issuance costs
Repayment of principal on convertible notes
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental cash flow information:
Cash paid for interest
Facility Notes principal converted to Series B-2 Preferred Stock
Conversion of Facility Notes into Series B-2 Preferred Stock
The 2019 Notes Converted to Common Stock
Commitment shares issued in connection with equity line of credit included in deferred offering costs
Amounts due for property and equipment included in accounts payable and accrued expenses
Amounts due for deferred offering costs included in accounts payable and accrued expenses
Cash paid in lieu of fractional shares in connection with 16-for-1 reverse stock split included in accounts payable and accrued expenses
Property and equipment financed under a lease agreement
Fair value of warrants issued to underwriters in connection with Public Offering
Right-of-use assets obtained in exchange for lease liabilities

Issuance of common stock in connection with the Merger (Note T)
Issuance of secured promissory note for the Merger (Note T)
Issuance of contingent value rights for the Merger (Note T)

Comments